Health Care/Hospital

Cally Wu, Vice President of Corporate HR, Asia Pacific, Eaton: How should businesses help themselves navigate through the COVID-19 crisis?

SHANGHAI, July 28, 2020 /PRNewswire/ -- "The COVID-19 crisis has now reached a new critical phase," Cally Wu, Vice President of Corporate HR,Asia Pacific, Eaton Corporation stated. "With every industry adapting to life during and post pandemic, new regulations being put in place have forced organ...

2020-07-28 16:33 2920

World Hepatitis Day: Health Experts Identify Major Disruptions to Hepatitis Elimination Efforts Caused by COVID-19

SINGAPORE, July 28, 2020 /PRNewswire/ -- On 24 July 2020, the Coalition to Eradicate Viral Hepatitis inAsia Pacific (CEVHAP) co-hosted a webinar with Burnet Institute, in collaboration with World Health Organization (WHO) Western Pacific Region and WHO South East Asia Region, inviting health ...

2020-07-28 15:48 2203

Ethicon #OrthopaedicMasters Webinar Series Featuring International Experts Sets Out to Improve Patient Outcomes

SINGAPORE, July 28, 2020 /PRNewswire/ -- Ethicon*, part of Johnson & Johnson Medical Devices Companies**, has convened orthopaedic experts and key opinion leaders from around the world to host theAsia Pacific #OrthopaedicMasters Series. This series of virtual events will run over several month...

2020-07-28 10:30 2900

AGC to Complete the Acquisition of MolMed on July 31, 2020

AGC Biologics adds leading-edge cell & gene therapy company in Milan, Italy SEATTLE, July 28, 2020 /PRNewswire/ -- AGC Biologics, a Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that they will acquire the majority of the share capital of Molec...

2020-07-28 10:00 3394

Equal Strategy Launches Eco Pure Room - World's First Odourless, Medical-Grade Ambient Sanitiser that Continually Eliminates Coronaviruses and Bacteria from Indoor Spaces

SINGAPORE, July 28, 2020 /PRNewswire/ -- Equal Strategy, a leading sensory branding consultancy based inSingapore has launched a new business arm, Eco Pure Room – an innovative, odour-free ambient sanitiser which continually sanitises indoor environments, helping hotels, offices, restaurants, g...

2020-07-28 09:00 3377

Rapid Medical Receives CE Mark for TIGERTRIEVER(TM) XL

TIGERTRIEVER XL is the largest stentriever available, designed to safely remove clots from intracranial vessels up to9mm in diameter YOKNEAM, Israel, July 28, 2020 /PRNewswire/ -- Rapid Medical , a company focused on the development of next generation neurovascular...

2020-07-28 08:00 2843

Geltor Raises $91.3M as Pandemic Exposes Need for Sustainable Protein Supply Chain

Biodesign Leader to Expand Its Sustainable Ingredients-as-a-Service™ Platform Globally SAN LEANDRO, California, July 28, 2020 /PRNewswire/ -- Geltor today announced the closing of a$91.3M Series B financing that will fuel the global expansion of its Ingredients-as-a-Service™ platform. The fundin...

2020-07-28 02:08 2343

Global Healthcare Interoperability Market to Witness Nearly Two-fold Growth by 2024

SANTA CLARA, California, July 27, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Global Healthcare Interoperability Market, Forecast to 2024, contends that interoperability has become a critical consideration for all health IT (HIT) applications. Countries where HIT interoperability stan...

2020-07-27 22:01 2631

Ping An Signs Agreement with Shionogi to Launch Joint Ventures

HONG KONG and SHANGHAI, July 27, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) is pleased to announce that agreements have been signed with Shionogi (Hong Kong) Company Ltd. ("Shionogi (Hong Kong)"), a wholly owned...

2020-07-27 17:10 21177

Manulife launches new flagship critical illness plans - ManuBright Care 2 and ManuBright Care 2 Plus

HONG KONG, July 27, 2020 /PRNewswire/ -- Manulife Hong Kong today announced the launch of two new critical illness ("CI") plans, ManuBright Care 2 ("MBC 2") and ManuBright Care 2 Plus ("MBC 2 Plus") (the "Plans"), designed to provide well-rounded and continuous protection for customers up to the ...

2020-07-27 16:52 4528

From The Alzheimer's Association International Conference 2020: Flu, Pneumonia Vaccinations Tied To Lower Risk Of Alzheimer's Dementia

CHICAGO, July 27, 2020 /PRNewswire/ -- Flu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer's disease, according to new research reported at theAlzheimer's Association International Conference ® (AAIC®) 2020. Three research studies reported at AAIC 2020 su...

2020-07-27 13:01 3720

Dow and Thong Guan introduces sustainable plastic stretch cling films made with renewable feedstock in Asia Pacific

SINGAPORE, July 27, 2020 /PRNewswire/ -- Dow (NYSE: DOW) and Thong Guan, one of the world's leading plastic stretch cling film producers, today introduced a new range of bio-based polyethylene (bio-PE) inAsia Pacific. This marks a milestone in the region's commercialization of a plastics offering...

2020-07-27 11:43 4797

Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA

HANGZHOU, China, July 27, 2020 /PRNewswire/ -- Lynk Pharmaceuticals (Hangzhou, China) is pleased to announce exclusive licensing agreements with Kobe University (Kobe, Japan) and with RIKEN Research Institute (Saitama, Japan) to develop RAS inhibitors with a novel MOA. The agreement withKobe Univ...

2020-07-27 07:00 3812

VISTA Eye Specialists Collaborates with Alcon Malaysia and Tigas Pharmacy to Raise Awareness on Dry Eyes

KUALA LUMPUR, Malaysia, July 25, 2020 /PRNewswire/ -- VISTA Eye Specialist (VISTA), in collaboration with Alcon Malaysia and Tigas Pharmacy, will be sharing via a Facebook Live Webinar on28 July 2020, 8.30pm titled 'Bye Bye Dry Eyes' discussing about the complete management of Dry Eyes Disease (D...

2020-07-25 08:00 5511

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

- Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development - Elacestrant further strengthens Menarini's global oncology portfolio, recently bolstered by the acquisition of Stemline Therapeutics in the U.S. - Radius...

2020-07-24 06:16 4311

COVID-19 Vaccines Test Safe & Effective by China & UK teams: the Lancet

BEIJING, July 24, 2020 /PRNewswire/ -- A news report by Science and Technology Daily: Good news. On July 20th, The Lancet published two papers online at the same time, revealing the results of clinical trials for two COVID-19 vaccines. From China and the United Kingdom respectively, the two stars...

2020-07-24 00:55 4014

Komodo Health Lauded by Frost & Sullivan for Empowering Healthcare Stakeholders with Dynamic Real-world Evidence Solutions

Komodo Health provides a powerful spectrum of data analysis software to cross-link the patient's care pathway data with other medical and healthcare datasets to better understand and predict disease SANTA CLARA, California, July 23, 2020 /PRNewswire/ -- Based on its recent analysis of the North ...

2020-07-23 23:00 3396

APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer

APCEDEN®, APAC's immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors (GBM) and pancreatic cancers (PDAC) with its new technology. DELHI, India, July 23, 2020 /...

2020-07-23 22:00 2799

King Power, Ministry of Tourism and Sports and TAT Launch Thailand Smiles With You campaign

BANGKOK, July 23, 2020 /PRNewswire/ -- King Power Group, in collaboration with the Ministry of Tourism and Sports, and the Tourism Authority ofThailand (TAT), announces a phenomenal campaign 'THAILAND SMILES WITH YOU' which aims to promote Thailand to the world through Leicester City FC, a UK prem...

2020-07-23 20:03 4044

N.B. Quadriga's Transformative Treatment for Brain Cancers Dosed in First Human Subject

SHANGHAI and NANTONG, China, July 23, 2020 /PRNewswire/ -- N.B. Quadriga (NBQ), a clinical stage biopharmaceutical company developing transformative medicines for brain cancers, today announced that the first patient has been dosed in a Phase 1 study of NBQ72S, also known as QBS10072S, in pati...

2020-07-23 19:00 3508
1 ... 432433434435436437438 ... 552